A revolutionary vaccine that could prevent cancer for people at high risk of bowel and ovarian cancer has been developed.

Lynch syndrome is an inherited condition affecting 1 in 300 people that causes lifetime cancer risk of up to 80%[1]The ...

A ‘TRANSFORMATIVE’ new vaccine that could prevent bowel and ovarian cancer has been developed by UK scientists. Scientists ...

Oxford and Moderna’s preventive mRNA cancer vaccine enters trials, targeting high-risk Lynch syndrome patients to train ...

The vaccine could help thousands of people with a faulty gene that makes them vulnerable to cancer ...

Dr. Matthew Grossman, an interventional endoscopist and gastroenterologist with Atlantic Health System in New Jersey, explained the relationship between Lynch syndrome and human DNA. "Think of DNA as ...

The Moderna Innovation and Technology Centre (MITC) at Harwell Science and Innovation Campus. Moderna and the University of Oxford in the UK have been cleared to start human trials of what could be ...

Fast Track Designation (FTD) recognizes NOUS-209’s potential to address a serious condition with significant unmet medical ...

Genotype-informed surveillance should pair colonoscopy with upper endoscopy when MLH1/MSH2 mutations or family history ...

On a recent car ride with my son, I asked him if he planned on being tested for Lynch syndrome, the cancer-related syndrome that I have. If I don't get some shelter Ooh yeah I'm gonna fade away. . ." ...